Skip to main content
UniHealth

Doctor search

Kim D Bullock, MD

Psychiatry · Palo Alto

NPI 1790842763

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
4
1 carrier
Offices
2

Offices

2 locations · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Research they published

43 papers · cited 1,662 times

Published as Kim D. Bullock at Stanford Medicine, Stanford University.

Research identity is not a guarantee of current clinical practice. Same name is not the same person — if this looks like someone else, tell us.

Most recent papers
2025Treatments for Functional Neurological Disorder: A Practical Guide for Program DevelopmentJournal of Neuropsychiatry
2024Feasibility and Acceptability of a Mobile App–Based TEAM-CBT (Testing Empathy Assessment Methods–Cognitive Behavioral Therapy) Intervention (Feeling Good) for Depression: Secondary Data AnalysisLast authorJMIR Mental Health
2024Examining the Efficacy of Extended Reality–Enhanced Behavioral Activation for Adults With Major Depressive Disorder: Randomized Controlled TrialJMIR Mental Health
2023Augmenting group hoarding disorder treatment with virtual reality discarding: A pilot study in older adultsJournal of Psychiatric Research
2023A Systematic Review of using Virtual and Augmented Reality for the Diagnosis and Treatment of Psychotic DisordersCurrent Treatment Options in Psychiatry
2023Functional neurological disorder is a feminist issueJournal of Neurology Neurosurgery & Psychiatry
See the 22 most recent papers
Earlier papers
2022Virtual Reality Behavioral Activation for Adults With Major Depressive Disorder: Feasibility Randomized Controlled TrialJMIR Mental Health
2021Translating Virtual Reality Cue Exposure Therapy for Binge Eating into a Real-World Setting: An Uncontrolled Pilot StudyJournal of Clinical Medicine
2020Virtual Reality Behavioral Activation as an Intervention for Major Depressive Disorder: Case ReportJMIR Mental Health
2020COVID-19 and mental health: A review and the role of telehealth and virtual realityDigital Medicine
2020Bringing Virtual Reality From Clinical Trials to Clinical Practice for the Treatment of Eating Disorders: An Example Using Virtual Reality Cue Exposure TherapyJournal of Medical Internet Research
2019Virtual Reality-Delivered Mirror Visual Feedback and Exposure Therapy for FND: A Midpoint Report of a Randomized Controlled Feasibility StudyFirst authorJournal of Neuropsychiatry
2019Key Considerations for Incorporating Conversational AI in PsychotherapyFrontiers in Psychiatry
2018Recommendations for Methodology of Virtual Reality Clinical Trials in Health Care by an International Working Group: Iterative StudyJMIR Mental Health
2015Group Dialectical-Behavior Therapy Skills Training for Conversion Disorder With SeizuresFirst authorJournal of Neuropsychiatry
2008Group therapy for patients with psychogenic nonepileptic seizures: A pilot studyEpilepsy & Behavior
2005Double-Blind Treatment With Oral Morphine in Treatment-Resistant Obsessive-Compulsive DisorderThe Journal of Clinical Psychiatry
2004Current Status of the Utilization of Antiepileptic Treatments in Mood, Anxiety and Aggression: Drugs and DevicesLast authorClinical EEG and Neuroscience
2003Citalopram for compulsive shopping disorder: an open-label study followed by double-blind discontinuation.PubMed
2003Psychopharmacology of compulsive buyingFirst authorDrugs of today
2002Citalopram Treatment of Compulsive ShoppingThe Journal of Clinical Psychiatry
1992Reduced Mortality Risk in Alcoholics Who Achieve Long-term AbstinenceFirst authorJAMA

Topics: Virtual Reality Applications and Impacts · Obsessive-Compulsive Spectrum Disorders · Psychosomatic Disorders and Their Treatments · Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes · Digital Mental Health Interventions

Plans that list them

4 plans · 1 carrier

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Bullock’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

Plans whose provider directory lists this clinician
SCAN Balance (HMO C-SNP)SCAN Health PlanListedOct 3, 2026
SCAN Classic (HMO)SCAN Health PlanListedOct 3, 2026
SCAN MyChoice (HMO)SCAN Health PlanListedOct 3, 2026
SCAN Strive (HMO C-SNP)SCAN Health PlanListedOct 3, 2026

California Medical Board record

Licence A56037 · Current

Licensed to practise in California · since 1996 · expires 2028-05-31 · George Washington University School of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Original Medicare doctor bills

$63,631

Medicare paid this office $63,631 for 26 people. Most of that is long return visits and Botox.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Long return visit (40+ min)17$33,010$170
Psychotherapy with evaluation and management visit, 1 hour19$21,266$110
Group psychotherapy13$5,307$25
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's13$989$15

Who their Medicare patients are

26 Original Medicare patients in 2024. Average age 65 · 85 and older 0% · Health risk score 1.09. At or below the middle of the specialty; the typical psychiatry clinician is at 1.35.

Conditions among them: Depression 73% · High blood pressure 50%.

The office billed $265,010, Medicare allowed $80,680 and paid $63,631; for 696 services of 13 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
202426696651.09$265,010$63,631
202325733621.12$199,388$32,503
202224518631.21$161,705$26,381
202113305661.29$89,758$16,145
202012323561.43$93,537$18,486
20191178691.12$29,031$6,443
201818120571.12$15,195$8,341
20172251601.09$6,745$2,695
20162094590.91$16,336$6,293
201518261551.31$39,510$17,264
201416327521.07$47,034$20,871
201321263581.15$41,790$13,856

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 5 services

Original Medicare services billed in 2023
Psychotherapy with evaluation and management visit, 1 hour15$8,234$107
Return visit (30+ min)11$7,080$118
Telehealth originating site facility fee24$6,696$21
Group psychotherapy16$5,461$23
Long return visit (40+ min)11$3,603$172

2022: 2 services

Original Medicare services billed in 2022
Telehealth originating site facility fee23$4,642$21
Group psychotherapy15$3,420$24

2021: 1 service

Original Medicare services billed in 2021
Telehealth originating site facility fee12$2,746$21

2013: 1 service

Original Medicare services billed in 2013
Return visit (30+ min)12$5,275$54

Drugs they prescribed that Part D paid

$594

Pharmacies billed $594 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 41) in 2024. Too few prescriptions to compare fairly with other clinicians.

41 generic and 0 brand-name prescriptions · $594 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Quetiapine12$97$8

Year by year

Part D prescribing by year
202441None0% (0)0%$594
202324None0% (0)0%$649
202224None0% (0)0%$2,635
202119None0% (0)0%$683
202030None0% (0)0%$567
201926None0% (0)0%$1,213
201824None0% (0)0%$1,558
201723None0% (0)0%$928
201641None0% (0)0%$1,321
201558None0% (0)0%$1,350
201450None0% (0)0%$7,221
201371NoneNoneNone$15,075

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2016: 1 drug

Part D drugs prescribed in 2016
Quetiapine12$518$43

2015: 2 drugs

Part D drugs prescribed in 2015
Quetiapine11$449$41
Lamotrigine16$218$14

2014: 1 drug

Part D drugs prescribed in 2014
Quetiapine17$6,189$364

2013: 2 drugs

Part D drugs prescribed in 2013
Quetiapine19$9,877$520
Clonazepam22$99$5

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
76.5 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1790842763
Licence
CA A56037California A56037: Current · expires 2028-05-31
Trained
George Washington University School of Medicine, 1994
Video visits
Lists video visits
Gender
Female
More record details
Sole proprietor
No
Taxonomy
Psychiatry (2084P0800X)
Mailing address
300 Pasteur Dr, Palo Alto, CA, 94304
NPI first listed
2007-01-02
NPI last updated
2024-04-29
NPI record certified
2024-04-29

This is when the NPI record was last certified, not a medical board exam.

Extra NPI addresses: 401 Quarry Rd, Palo Alto, CA, 94304